Answers are grounded in this paper and cite their sources.
The gut and the liver have a bidirectional communication via the biliary system and the portal vein. The intestinal microbiota and microbial products play an important role for modulating liver diseases such as alcohol-associated liver disease, non-alcoholic fatty liver disease and steatohepatitis, and cholestatic liver diseases. Here, we review the role of the gut microbiota and its products for the pathogenesis and therapy of chronic liver diseases.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: